Ranibizumab and the Risk of Arterial Thromboembolic Events
Clinical trial NCT01319188 · TERMINATED
Trial details
- NCT number
- NCT01319188
- Sponsor
- Ural State Medical University
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.